PillDexamethasone Sodium Phosphate
Brands: Dmt Suik · Dexamethasone Sodium Phosphate
15 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it15 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi USA, LLC | unknown | 11 | SUPPLYING |
| Sportpharm LLC | unknown | 3 | SUPPLYING |
| Asclemed USA, Inc. | unknown | 2 | SUPPLYING |
| HF Acquisition Co LLC, DBA HealthFirst | unknown | 2 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 2 | SUPPLYING |
| Mylan Institutional LLC | unknown | 2 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 1 | SUPPLYING |
| Somerset Therapeutics, LLC | unknown | 1 | SUPPLYING |
| Henry Schein Inc. | unknown | 1 | SUPPLYING |
| Phlow Corporation | unknown | 1 | SUPPLYING |
| Armas Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| Advanced Rx of Tennessee, LLC | unknown | 1 | SUPPLYING |
| Micro Labs Limited | unknown | 1 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
| Cardinal Health 107, LLC | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 4, 2026RECALLRecall (Class II): Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufa…
Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate. — Recalling firm: SOMERSET THERAPEUTICS LLC — Nationwide in the USA
- Feb 8, 2019SHORTAGEDrug shortage: Dexamethasone Sodium Phosphate Injection (Fresenius Kabi USA, LLC)
Dexamethasone Sodium Phosphate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology.